Results 131 to 140 of about 69,158 (295)

Probing Intracellular Yeast Metabolism With Deuterium Magnetic Resonance Spectroscopy

open access: yesNMR in Biomedicine, Volume 38, Issue 10, October 2025.
Deuterium magnetic resonance spectroscopy (DMRS) provides a straightforward, noninvasive method for monitoring real‐time metabolic flux. We determined the T1, T2, and chemical shifts for 26 deuterium‐labeled compounds in phosphate‐buffered saline. DMRS showed the consumption of pyruvate, glucose, fumarate, acetone, and nicotinamide, and let us test ...
Fatima Anum   +13 more
wiley   +1 more source

Breaking Free From MCHC Interferences? French‐Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 5, Page 798-807, October 2025.
ABSTRACT Mean corpuscular haemoglobin concentration (MCHC) is determined by the ratio of haemoglobin concentration to haematocrit. Managing increased MCHC presents significant challenges, mainly due to variations in analytical methods and pathophysiological conditions.
Sandrine Girard   +7 more
wiley   +1 more source

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. [PDF]

open access: yes, 2020
Arginine vasopressin (AVP) and its type-2 receptor (V2R) play an essential role in the regulation of salt and water homeostasis by the kidneys. V2R activation also stimulates proliferation of renal cell carcinoma (RCC) cell lines in vitro.
Calvet, James P   +10 more
core  

Modulation of Sodium and Ammonia Transporters in the Context of Viral Gill Diseases in Common Carp (Cyprinus carpio)

open access: yesJournal of Fish Diseases, Volume 48, Issue 10, October 2025.
ABSTRACT Osmoregulation and ammonia removal are among key physiological processes that take place in gills and affect fish homeostasis and well‐being. These processes can be disrupted by numerous environmental factors, but also by viral infections, especially those leading to severe gill disorders.
Maria Zawisza   +5 more
wiley   +1 more source

Nationwide Trends in Short‐Term Outcomes After Low Anterior Resection for Rectal Cancer: A Pre‐ and Post‐COVID‐19 Analysis From the Japanese National Clinical Database, 2018–2023

open access: yesAnnals of Gastroenterological Surgery, Volume 9, Issue 5, Page 1029-1035, September 2025.
Despite initial challenges, the healthcare system of Japan effectively managed rectal cancer surgeries during and after the COVID‐19 pandemic. Robotic surgery became more widely adopted, and complication rates improved, demonstrating resilience and adaptability in surgical care.
Ryo Seishima   +13 more
wiley   +1 more source

An Open‐Label, Single‐Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non‐Small Cell Lung Cancer After First‐Line PD‐(L)1 Inhibitor

open access: yesCancer Medicine, Volume 14, Issue 17, September 2025.
ABSTRACT Background Although immune checkpoint inhibitors (ICIs) have markedly improved first‐line management of non‐small cell lung cancer (NSCLC), many tumors eventually escape control after anti‐PD‐(L)1 therapy, leaving a clear therapeutic gap.
Xun Shi   +10 more
wiley   +1 more source

Hyponatremia and hyperkalemia associated with idiopathic or experimentally induced chylothorax in four dogs [PDF]

open access: bronze, 1991
Μ. D. Willard   +3 more
openalex   +1 more source

The Faculty Notebook, September 2002

open access: yes, 2002
The Faculty Notebook is published periodically by the Office of the Provost at Gettysburg College to bring to the attention of the campus community accomplishments and activities of academic interest.
Provost\u27s Office,
core  

Cytokine release syndrome in solid tumors

open access: yesCancer, Volume 131, Issue 17, 1 September 2025.
Abstract Cytokine release syndrome (CRS) is a common and potentially severe complication of cancer immunotherapy, including CAR T‐cell therapies, bispecific T‐cell engagers, and less commonly immune checkpoint inhibitors. Although extensive research has established guidelines for managing CRS in hematological malignancies, there is a growing need to ...
David Synnott   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy